Europe Specialty Generics Market Report by Route of Administration (Injectables, Oral, and Others), Indication (Oncology, Autoimmune Diseases, Infectious Diseases, and Others), Distributional Channel (Retail Pharmacies, Specialty Pharmacies, Hospital Pharmacies), and Region 2025-2033

Europe Specialty Generics Market Report by Route of Administration (Injectables, Oral, and Others), Indication (Oncology, Autoimmune Diseases, Infectious Diseases, and Others), Distributional Channel (Retail Pharmacies, Specialty Pharmacies, Hospital Pharmacies), and Region 2025-2033

Report Format: PDF+Excel | Report ID: SR112025A1266

​1   Preface
2   Scope and Methodology

    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3   Executive Summary
4   Europe Specialty Generics Market: Introduction
5   Why are Specialty Generics So Lucrative?
6   Europe Specialty Generics Market

    6.1    Market Overview
    6.2    Market Performance
    6.3    Impact of COVID-19
    6.4    Market Breakup by Route of Administration
    6.5    Market Breakup by Indication
    6.6    Market Breakup by Distribution Channel
    6.7    Market Breakup by Region
    6.8    Market Forecast
    6.9    SWOT Analysis
        6.9.1    Overview
        6.9.2    Strengths
        6.9.3    Weaknesses
        6.9.4    Opportunities
        6.9.5    Threats
    6.10    Value Chain Analysis
    6.11    Porters Five Forces Analysis
        6.11.1    Overview
        6.11.2    Bargaining Power of Buyers
        6.11.3    Bargaining Power of Suppliers
        6.11.4    Degree of Competition
        6.11.5    Threat of New Entrants
        6.11.6    Threat of Substitutes
    6.12    Key Market Drivers and Success Factors
7   Market Breakup by Route of Administration
    7.1    Injectable
        7.1.1    Market Trends
        7.1.2    Market Forecast
    7.2    Oral
        7.2.1    Market Trends
        7.2.2    Market Forecast
    7.3    Others
        7.3.1    Market Trends
        7.3.2    Market Forecast
8   Market Breakup by Indication
    8.1    Oncology
        8.1.1    Market Trends
        8.1.2    Market Forecast
    8.2    Autoimmune Diseases
        8.2.1    Market Trends
        8.2.2    Market Forecast
    8.3    Infectious Diseases
        8.3.1    Market Trends
        8.3.2    Market Forecast
    8.4    Others
        8.4.1    Market Trends
        8.4.2    Market Forecast
9   Market Breakup by Distribution Channel
    9.1    Retail Pharmacies
        9.1.1    Market Trends
        9.1.2    Market Forecast
    9.2    Specialty Pharmacies
        9.2.1    Market Trends
        9.2.2    Market Forecast
    9.3    Hospital Pharmacies
        9.3.1    Market Trends
        9.3.2    Market Forecast
10  Market Breakup by Region
    10.1    Germany
        10.1.1    Market Trends
        10.1.2    Market Forecast
    10.2    France
         10.2.1    Market Trends
         10.2.2    Market Forecast
    10.3   United Kingdom
         10.3.1    Market Overview
         10.3.2    Market Performance
     10.4    Spain
          10.4.1    Market Performance
          10.4.2    Market Forecast
       10.5    Others
           10.5.1    Market Trends
           10.5.2    Market Forecast
11  Competitive Landscape
    11.1    Market Structure
    11.2    Key Players

List of Figures

Figure 1: Europe: Specialty Generics Market: Sales Value (in Billion USD), 2019-2024
Figure 2: Europe: Specialty Generics Market: Breakup by Route of Administration (in %), 2024
Figure 3: Europe: Specialty Generics Market: Breakup by Indication (in %), 2024
Figure 4: Europe: Specialty Generics Market: Breakup by Distribution Channel (in %), 2024
Figure 5: Europe: Specialty Generics Market: Breakup by Region (in %), 2024
Figure 6: Europe: Specialty Generics Market Forecast: Sales Value (in Billion USD), 2025-2033
Figure 7: Europe: Specialty Generics Industry: SWOT Analysis
Figure 8: Europe: Specialty Generics Industry: Value Chain Analysis
Figure 9: Europe: Specialty Generics Industry: Porter’s Five Forces Analysis
Figure 10: Europe: Specialty Generics Market (Administration through Injectables): Sales Value (in Billion USD), 2019 & 2024
Figure 11: Europe: Specialty Generics Market (Administration through Injectables) Forecast: Sales Value (in Billion USD), 2025-2033
Figure 12: Europe: Specialty Generics Market (Oral Administration): Sales Value (in Billion USD), 2019 & 2024
Figure 13: Europe: Specialty Generics Market (Oral Administration) Forecast: Sales Value (in Billion USD), 2025-2033
Figure 14: Europe: Specialty Generics Market (Other Routes of Administration): Sales Value (in Billion USD), 2019 & 2024
Figure 15: Europe: Specialty Generics Market (Other Routes of Administration) Forecast: Sales Value (in Billion USD), 2025-2033
Figure 16: Europe: Specialty Generics Market (Oncology): Sales Value (in Billion USD), 2019 & 2024
Figure 17: Europe: Specialty Generics Market (Oncology) Forecast: Sales Value (in Billion USD), 2025-2033
Figure 18: Europe: Specialty Generics Market (Autoimmune Diseases): Sales Value (in Billion USD), 2019 & 2024
Figure 19: Europe: Specialty Generics Market (Autoimmune Diseases) Forecast: Sales Value (in Billion USD), 2025-2033
Figure 20: Europe: Specialty Generics Market (Infectious Diseases): Sales Value (in Billion USD), 2019 & 2024
Figure 21: Europe: Specialty Generics Market (Infectious Diseases) Forecast: Sales Value (in Billion USD), 2025-2033
Figure 22: Europe: Specialty Generics Market (Other Indications): Sales Value (in Billion USD), 2019 & 2024
Figure 23: Europe: Specialty Generics Market (Other Indications) Forecast: Sales Value (in Billion USD), 2025-2033
Figure 24: Europe: Specialty Generics Market: Sales through Retail Pharmacies (in Billion USD), 2019 & 2024
Figure 25: Europe: Specialty Generics Market Forecast: Sales through Retail Pharmacies (in Billion USD), 2025-2033
Figure 26: Europe: Specialty Generics Market: Sales through Specialty Pharmacies (in Billion USD), 2019 & 2024
Figure 27: Europe: Specialty Generics Market Forecast: Sales through Specialty Pharmacies (in Billion USD), 2025-2033
Figure 28: Europe: Specialty Generics Market: Sales through Hospital Pharmacies (in Billion USD), 2019 & 2024
Figure 29: Europe: Specialty Generics Market Forecast: Sales through Hospital Pharmacies (in Billion USD), 2025-2033
Figure 30: Germany: Specialty Generics Market: Sales Value (in Billion USD), 2019 & 2024
Figure 31: Germany: Specialty Generics Market Forecast: Sales Value (in Billion USD), 2025-2033
Figure 32: United Kingdom: Specialty Generics Market: Sales Value (in Billion USD), 2019 & 2024
Figure 33: United Kingdom: Specialty Generics Market Forecast: Sales Value (in Billion USD), 2025-2033
Figure 34: France: Specialty Generics Market: Sales Value (in Billion USD), 2019 & 2024
Figure 35: France: Specialty Generics Market Forecast: Sales Value (in Billion USD), 2025-2033
Figure 36: Italy: Specialty Generics Market: Sales Value (in Billion USD), 2019 & 2024
Figure 37: Italy: Specialty Generics Market Forecast: Sales Value (in Billion USD), 2025-2033
Figure 38: Spain: Specialty Generics Market: Sales Value (in Billion USD), 2019 & 2024
Figure 39: Spain: Specialty Generics Market Forecast: Sales Value (in Billion USD), 2025-2033
Figure 40: Rest of Europe: Specialty Generics Market: Sales Value (in Billion USD), 2019 & 2024
Figure 41: Rest of Europe: Specialty Generics Market Forecast: Sales Value (in Billion USD), 2025-2033

List of Tables

Table 1: Europe: Specialty Generics Market: Key Industry Highlights, 2024 and 2033
Table 2: Europe: Specialty Generics Market Forecast: Breakup by Route of Administration (in Billion USD), 2025-2033
Table 3: Europe: Specialty Generics Market Forecast: Breakup by Indication (in Billion USD), 2025-2033
Table 4: Europe: Specialty Generics Market Forecast: Breakup by Distribution Channel (in Billion USD), 2025-2033
Table 5: Europe: Specialty Generics Market Forecast: Breakup by Region (in Billion USD), 2025-2033
Table 6: Europe: Specialty Generics Market Structure
Table 7: Europe: Specialty Generics Market: Key Players

Europe Specialty Generics Market Report by Route of Administration (Injectables, Oral, and Others), Indication (Oncology, Autoimmune Diseases, Infectious Diseases, and Others), Distributional Channel (Retail Pharmacies, Specialty Pharmacies, Hospital Pharmacies), and Region 2025-2033
Purchase Options New Year Sale
Benefits of Customization
  • Personalize this research
  • Triangulate with your data
  • Get data as per your format and definition
  • Gain a deeper dive into a specific application, geography, customer, or competitor
  • Any level of personalization

Get in Touch With Us

UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-714-6104

Email: sales@imarcgroup.com

Client Testimonials